<?xml version="1.0" encoding="UTF-8" standalone="no"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:blogger="http://schemas.google.com/blogger/2008" xmlns:gd="http://schemas.google.com/g/2005" xmlns:georss="http://www.georss.org/georss" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/" xmlns:thr="http://purl.org/syndication/thread/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-2073471180688448934</atom:id><lastBuildDate>Sat, 31 Aug 2024 14:23:25 +0000</lastBuildDate><title>Minneapolis Heart Institute Foundation Cardiology Grand Rounds</title><description>As part of our mission to end cardiovascular disease, The Minneapolis Heart Institute Foundation offers weekly cardiology Grand Rounds to stay up-to-date on the latest developments in cardiology. These weekly meetings feature topics from the following cardiac specialty areas: congestive heart failure, electrophysiology, cardiac imaging, interventional cardiology, heart disease prevention, cardiac surgery, vascular/endovascular and miscellaneous.</description><link>http://mhifgrandrounds.blogspot.com/</link><managingEditor>noreply@blogger.com (Minneapolis Heart Institute Foundation)</managingEditor><generator>Blogger</generator><openSearch:totalResults>12</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><language>en-us</language><itunes:explicit>no</itunes:explicit><itunes:image href="http://sphotos.xx.fbcdn.net/hphotos-ash4/2730_68455643619_68434303619_1595641_6513411_n.jpg"/><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords><itunes:summary>As part of our mission to end cardiovascular disease, The Minneapolis Heart Institute Foundation offers weekly cardiology Grand Rounds to stay up-to-date on the latest developments in cardiology. These weekly meetings feature topics from the following cardiac specialty areas: congestive heart failure, electrophysiology, cardiac imaging, interventional cardiology, heart disease prevention, cardiac surgery, vascular/endovascular and other related topics. Visit http://www.mplsheart.org for more information.</itunes:summary><itunes:subtitle>Stay up-to-date on the latest developments in cardiology.</itunes:subtitle><itunes:category text="Science &amp; Medicine"><itunes:category text="Medicine"/></itunes:category><itunes:category text="Education"><itunes:category text="Higher Education"/></itunes:category><itunes:category text="Government &amp; Organizations"><itunes:category text="Non-Profit"/></itunes:category><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:owner><itunes:email>kwincek@mhif.org</itunes:email><itunes:name>Minneapolis Heart Institute Foundation</itunes:name></itunes:owner><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-7957048915716160184</guid><pubDate>Mon, 30 Jan 2012 13:00:00 +0000</pubDate><atom:updated>2012-03-12T15:53:35.061-05:00</atom:updated><title>Riata ICD Leads: Is there a problem or just a cosmetic issue?</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Dr. Raed H. Abdelhadi&lt;/b&gt;, Cardiac Electrophysiologist at the &lt;b&gt;Minneapolis Heart Institute&lt;/b&gt; at &lt;b&gt;Abbott Northwestern Hospital&lt;/b&gt;, reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/Abdelhadi.mp3"/><link>http://mhifgrandrounds.blogspot.com/2012/01/riata-icd-leads-is-there-problem-or.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Raed H. Abdelhadi, Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Raed H. Abdelhadi, Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary results for the Riata Multicenter Study, discusses the challenges regarding screening and management and summarizes the Riata Summit.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-388278522978053333</guid><pubDate>Mon, 16 Jan 2012 13:00:00 +0000</pubDate><atom:updated>2012-03-12T15:49:19.534-05:00</atom:updated><title>Decongestive Strategies in Acute Heart Failure</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Dr. Steven R. Goldsmith&lt;/b&gt;, Professor of Medicine at the &lt;b&gt;University of Minnesota&lt;/b&gt;, Director of the &lt;b&gt;Heart Failure Program&lt;/b&gt; at &lt;b&gt;Hennepin County Medical Center&lt;/b&gt;, and Director of the &lt;b&gt;Minnesota Heart Failure Consortium&lt;/b&gt;, explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/Goldsmith.mp3"/><link>http://mhifgrandrounds.blogspot.com/2012/01/decongestive-strategies-in-acute-heart.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Steven R. Goldsmith, Professor of Medicine at the University of Minnesota, Director of the Heart Failure Program at Hennepin County Medical Center, and Director of the Minnesota Heart Failure Consortium, explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Steven R. Goldsmith, Professor of Medicine at the University of Minnesota, Director of the Heart Failure Program at Hennepin County Medical Center, and Director of the Minnesota Heart Failure Consortium, explains the importance of congestion as a contributor to the pathophysiology of acute heart failure, describes the limits of current decongestive strategies and the promise of newer modalities and discusses emerging insights concerning the relationship between congestion and the cardiorenal syndrom in acute heart failure.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-1811631786770862104</guid><pubDate>Mon, 19 Dec 2011 13:00:00 +0000</pubDate><atom:updated>2012-03-12T15:43:11.668-05:00</atom:updated><title>Atrial Fibrillation: New Agents for Stroke Prevention</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Dr. R. Jeffrey Westcott&lt;/b&gt;, Medical Director at the &lt;b&gt;Cardiac Cath Lab at the Swedish Heart and Vascular Institute&lt;/b&gt;, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/Westcott_mp3.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/12/atrial-fibrillation-new-agents-for.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience bleeding complications and discusses the advantages of these agents versus warfarin in treating patients with non-valvular atrial fibrillation.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-2050528137087470941</guid><pubDate>Mon, 28 Nov 2011 13:00:00 +0000</pubDate><atom:updated>2012-03-12T15:38:39.930-05:00</atom:updated><title>TCT/AHA Highlights: Platelets and Stem Cells</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Dr. Timothy Henry&lt;/b&gt;, Director of Research at the &lt;b&gt;Minneapolis Heart Institute Foundation&lt;/b&gt;, and &lt;b&gt;Dr. Jay Traverse&lt;/b&gt;, Senior Consulting Cardiologist at the &lt;b&gt;Minneapolis Heart Institute&lt;/b&gt; at &lt;b&gt;Abbott Northwestern Hospital&lt;/b&gt;, review the results of the LateTIME, SCIPIO and CADUCEUS trials.&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/HenryTraverse.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/11/tctaha-highlights-platelets-and-stem.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Timothy Henry, Director of Research at the Minneapolis Heart Institute Foundation, and Dr. Jay Traverse, Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, review the results of the LateTIME, SCIPIO and CADUCEUS trials.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Timothy Henry, Director of Research at the Minneapolis Heart Institute Foundation, and Dr. Jay Traverse, Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, review the results of the LateTIME, SCIPIO and CADUCEUS trials.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-6741829224291947658</guid><pubDate>Mon, 21 Nov 2011 13:00:00 +0000</pubDate><atom:updated>2012-03-12T15:33:43.508-05:00</atom:updated><title>Update in Preventive Cardiology 2011</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Dr. Thomas Knickelbine&lt;/b&gt;, Director of Preventive Cardiology at the &lt;b&gt;Minneapolis Heart Institute&lt;/b&gt; at &lt;b&gt;Abbott Northwestern Hospital&lt;/b&gt; discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines &lt;b&gt;MHI&lt;/b&gt; prevention goals and future vision.&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/Knickelbine.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/11/update-in-preventive-cardiology-2011.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Thomas Knickelbine, Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Thomas Knickelbine, Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current approaches to treatment of non-HDL cholesterol and Metabolic Syndrome and outlines MHI prevention goals and future vision.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-7543017841343604508</guid><pubDate>Mon, 31 Oct 2011 12:00:00 +0000</pubDate><atom:updated>2012-03-12T15:26:58.356-05:00</atom:updated><title>AHA Abstract Presentations</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by &lt;b&gt;Dr. Kevin M. Harris&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by &lt;b&gt;Dr. Ronald Reiter&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, &lt;b&gt;Kalie Y. Kebed&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. &lt;b&gt;Michael D. Miedema&lt;/b&gt;&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/AHASessions.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/10/aha-abstract-presentations.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. Harris Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. Harris Circadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial Infarction - Presented by Dr. Ronald Reiter Cardiogenic Shock in Cardiac Arrest No Longer a Contraindication for Therapeutic Hypothermia - Presented by Fourth-Year Medical Student, Kalie Y. Kebed Prevalence of Premature Coronary Heart Disease and Female Gender in Patients Presenting with ST-Elevation Myocardial Infarction - Presented by Dr. Michael D. Miedema</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-3099171611814202922</guid><pubDate>Mon, 24 Oct 2011 12:00:00 +0000</pubDate><atom:updated>2012-03-12T15:19:52.893-05:00</atom:updated><title>Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Dr. Steve Levin&lt;/b&gt;, Vascular Fellow at the &lt;b&gt;University of Minnesota&lt;/b&gt;, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/Levin.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/10/critical-limb-ischemia-is-there-role.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have performed relative to balloon angioplasty and bare metal stenting in patients suffering from critical limb ischemia.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-2066097695890611963</guid><pubDate>Mon, 17 Oct 2011 12:00:00 +0000</pubDate><atom:updated>2012-03-12T15:16:01.202-05:00</atom:updated><title>Repairing Valves: Why and Why Not?</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;b&gt;Dr. Benjamin Sun&lt;/b&gt;, Chair of Cardiac, Thoracic and Transplant Surgery at the &lt;b&gt;Minneapolis Heart Institute&lt;/b&gt; at &lt;b&gt;Abbott Northwestern Hospital&lt;/b&gt;, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/system/files/Sun_mp3.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/10/repairing-valves-why-and-why-not.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Benjamin Sun, Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Benjamin Sun, Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes when valve replacement is still preferred.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-2020246339192450006</guid><pubDate>Mon, 03 Oct 2011 12:00:00 +0000</pubDate><atom:updated>2012-02-22T15:19:08.998-06:00</atom:updated><title>Cardiac Resynchronization Therapy: Developing a Center of Excellence</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;br /&gt;
&lt;div class="MsoNormal"&gt;
&lt;span style="font-family: inherit;"&gt;&lt;b&gt;Dr. Alan J. Bank&lt;/b&gt;,&amp;nbsp;Medical Director of Research at &lt;b&gt;United Heart and
Vascular Clinic&lt;/b&gt;, and&lt;/span&gt;&lt;/div&gt;
&lt;div class="MsoNormal"&gt;
&lt;span style="font-family: inherit;"&gt;Associate Professor of Cardiology at the &lt;b&gt;University of
Minnesota&lt;/b&gt;, describes the components of a CRT Center
     of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical
     dyssynchrony in heart failure, and describes the effects of CRT in patients
     with NYHA Class II heart failure.&lt;/span&gt;&lt;/div&gt;
&lt;br /&gt;&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/system/files/Bank.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/10/cardiac-resynchronization-therapy.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Alan J. Bank,&amp;nbsp;Medical Director of Research at United Heart and Vascular Clinic, and Associate Professor of Cardiology at the University of Minnesota, describes the components of a CRT Center of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical dyssynchrony in heart failure, and describes the effects of CRT in patients with NYHA Class II heart failure.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Alan J. Bank,&amp;nbsp;Medical Director of Research at United Heart and Vascular Clinic, and Associate Professor of Cardiology at the University of Minnesota, describes the components of a CRT Center of Excellence, explains the mechanisms of action of CRT, discusses the importance of mechanical dyssynchrony in heart failure, and describes the effects of CRT in patients with NYHA Class II heart failure.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-6681767699669658413</guid><pubDate>Mon, 26 Sep 2011 12:00:00 +0000</pubDate><atom:updated>2012-02-22T15:14:52.412-06:00</atom:updated><title>A Serious Complication of a Common Vascular Practice</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;br /&gt;
&lt;div class="MsoNormal"&gt;
&lt;span style="font-family: inherit;"&gt;&lt;b&gt;Dr. Nedaa Skeik&lt;/b&gt;,&amp;nbsp;Vascular Medicine Consultant at the &lt;b&gt;Minneapolis Heart
Institute®&lt;/b&gt; at&lt;/span&gt;&lt;/div&gt;
&lt;div class="MsoNormal"&gt;
&lt;span style="font-family: inherit;"&gt;&lt;b&gt;Abbott Northwestern Hospital&lt;/b&gt;, explains different treatment modalities
     for deep vein thrombosis (DVT), describes the history of inferior vena
     cava (IVC) filters, lists indications and
     complications&amp;nbsp;(common and rare) of IVC filters, and explains identification and management
     of arterial pseudoaneurysm as a rare complication of IVC filters.&lt;/span&gt;&lt;/div&gt;
&lt;ol start="1" style="margin-top: 0in;" type="1"&gt;
&lt;/ol&gt;
&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/system/files/Skeik.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/09/serious-complication-of-common-vascular.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Nedaa Skeik,&amp;nbsp;Vascular Medicine Consultant at the Minneapolis Heart Institute® at Abbott Northwestern Hospital, explains different treatment modalities for deep vein thrombosis (DVT), describes the history of inferior vena cava (IVC) filters, lists indications and complications&amp;nbsp;(common and rare) of IVC filters, and explains identification and management of arterial pseudoaneurysm as a rare complication of IVC filters.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Nedaa Skeik,&amp;nbsp;Vascular Medicine Consultant at the Minneapolis Heart Institute® at Abbott Northwestern Hospital, explains different treatment modalities for deep vein thrombosis (DVT), describes the history of inferior vena cava (IVC) filters, lists indications and complications&amp;nbsp;(common and rare) of IVC filters, and explains identification and management of arterial pseudoaneurysm as a rare complication of IVC filters.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-1023869351684387935</guid><pubDate>Mon, 19 Sep 2011 12:00:00 +0000</pubDate><atom:updated>2012-02-22T15:15:15.213-06:00</atom:updated><title>Sudden Death, Risk Stratification and Prevention in Hypertrophic Cardiomyopathy</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;div class="MsoNormal"&gt;
&lt;span style="font-family: inherit;"&gt;&lt;b&gt;Dr. Barry J. Maron&lt;/b&gt;,&amp;nbsp;Director of&lt;b&gt;&amp;nbsp;&lt;/b&gt;the&lt;b&gt; Hypertrophic Cardiomyopathy Center&lt;/b&gt; at the &lt;b&gt;Minneapolis Heart Institute&lt;/b&gt; at &lt;b&gt;Abbott-Northwestern Hospital&lt;/b&gt; looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/system/files/Maron%20091911.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/09/sudden-death-risk-stratification-and.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Dr. Barry J. Maron,&amp;nbsp;Director of&amp;nbsp;the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Dr. Barry J. Maron,&amp;nbsp;Director of&amp;nbsp;the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-2073471180688448934.post-6259580433047038843</guid><pubDate>Mon, 12 Sep 2011 12:00:00 +0000</pubDate><atom:updated>2012-02-22T15:19:38.953-06:00</atom:updated><title>Pacing the Heart: What side are you on?</title><description>&lt;div dir="ltr" style="text-align: left;" trbidi="on"&gt;
&lt;span style="font-family: inherit;"&gt;Senior Consulting Cardiologist&lt;span style="font-size: small;"&gt; at the &lt;/span&gt;&lt;b&gt;Minneapolis Heart Institute&lt;/b&gt;&lt;span style="font-size: small;"&gt; at &lt;/span&gt;&lt;b&gt;Abbott-Northwestern Hospital&lt;/b&gt;&lt;span style="font-size: small;"&gt;, &lt;/span&gt;&lt;b&gt;Dr. Robert Hauser&lt;/b&gt;&lt;span style="font-size: small;"&gt;, su&lt;/span&gt;&lt;span style="text-indent: -0.25in;"&gt;mmarizes pacing
hemodynamics, d&lt;/span&gt;&lt;span style="text-indent: -0.25in;"&gt;escribes the
value of cardiac synchronization, and e&lt;/span&gt;&lt;span style="text-indent: -0.25in;"&gt;xplains ICD
reliability and patient longevity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</description><enclosure length="0" type="audio/mpeg" url="http://www.mplsheart.org/sites/all/default/userfiles/Grand_Rounds_091211_Hauser.mp3"/><link>http://mhifgrandrounds.blogspot.com/2011/09/pacing-heard-what-side-are-you-on.html</link><thr:total>0</thr:total><author>kwincek@mhif.org (Minneapolis Heart Institute Foundation)</author><itunes:explicit>no</itunes:explicit><itunes:subtitle>Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott-Northwestern Hospital, Dr. Robert Hauser, summarizes pacing hemodynamics, describes the value of cardiac synchronization, and explains ICD reliability and patient longevity.</itunes:subtitle><itunes:author>Minneapolis Heart Institute Foundation</itunes:author><itunes:summary>Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott-Northwestern Hospital, Dr. Robert Hauser, summarizes pacing hemodynamics, describes the value of cardiac synchronization, and explains ICD reliability and patient longevity.</itunes:summary><itunes:keywords>Minneapolis,Heart,Institute,Foundation,cardiology,Grand,Rounds,cardiovascular,heart,disease,prevention,cardiac,surgery,interventional,cardiology,electrophysiology,vascular,endovascular</itunes:keywords></item></channel></rss>